AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study NCT02405637 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: distilled water
Description: distilled water 20 ml/kg/day for maximum of 7 days.
Study NCT01693237 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Group psychotherapy
Description: 20 sessions of systemic and narrative group therapy
Study NCT01693237 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Group psychotherapy with feedback
Description: 20 sessions of systemic and narrative group therapy
Study NCT03967574 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Transcranial direct current stimulation
Description: The tDCS anode was applied on the primary motor cortex area responsible for the control of the rotator cuff, as determined using transcranial magnetic stimulation and surface electromyography. The cathode was applied on the contralateral forehead, just above the eyebrow. The electrodes were soaked in saline solution to improve conductivity and the montage was secured with rubber bands and adhesive tape.~The tDCS device (Soterix Medical 1x1 tDCS device) was then gradually turned to an intensity of 2mA. This stimulation was continued for a total of 20 minutes, after which it was gradually stopped.
Study NCT03967574 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Transcranial direct current stimulation
Description: The tDCS anode was applied on the primary motor cortex area responsible for the control of the rotator cuff, as determined using transcranial magnetic stimulation and surface electromyography. The cathode was applied on the contralateral forehead, just above the eyebrow. The electrodes were soaked in saline solution to improve conductivity and the montage was secured with rubber bands and adhesive tape.~The tDCS device (Soterix Medical 1x1 tDCS device) was then gradually turned to an intensity of 2mA. This stimulation was continued for a total of 20 minutes, after which it was gradually stopped.
Study NCT01032343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: ACTIVE_COMPARATOR
Intervention: Omega-3 PUFA
Description: One capsule (4g omega-3 PUFA) daily for 3 months
Study NCT01032343 — intervention group
Intervention type: DIETARY_SUPPLEMENT
Group type: PLACEBO_COMPARATOR
Intervention: Gelatine
Description: One capsule daily for 3 months
Study NCT00785447 — intervention group
Intervention type: OTHER
Group type: OTHER
Intervention: Mouth-to-mouth or mouth-to-nose breathing
Description: Patients undergoing elective surgery under general anesthesia will be given mouth-to-mouth and mouth-to-nose breaths. The respiration process will be measured and recorded by the help of elastic bands put around the chest and abdomen. The efficiency of the breathing methods will be evaluated.
Study NCT02243826 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: 50:50 mixture of nitrous oxide/oxygen
Study NCT02243826 — intervention group
Intervention type: DRUG
Group type: OTHER
Intervention: 50:50 mixture of nitrous oxide/oxygen
Study NCT04555733 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Lemborexant
Description: Lemborexant oral tablets.
Study NCT02691377 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: acupuncture group
Description: Acupoints include 11 on the head, two on the upper extremities, and two on the lower extremities. Before performing acupuncture, a small pad will be pasted on each acupoint. All the needles will insert the acupoints through these pads. Then, they will be twirled, lifted and thrust three times to elicit the Deqi sensation. Each session will last 30 minutes.
Study NCT02691377 — intervention group
Intervention type: DEVICE
Group type: SHAM_COMPARATOR
Intervention: Sham Acupuncture group
Description: The same acupoints with acupuncture group are selected.A placebo needle with a blunt tip will be used to perform sham acupuncture. They will only insert the pad and no skin penetration. The same procedure with acupuncture group will be performed.
Study NCT03987880 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: 4.0 mm treatment
Description: PiXL treatment with UV irradiation in a central 4.0-mm ring-shaped zone of the cornea.
Study NCT03987880 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: 3.5 mm treatment
Description: PiXL treatment with UV irradiation in a central 3.5-mm ring-shaped zone of the cornea.
Study NCT02178436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Description: Given IV
Study NCT02246036 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: APD probe
Description: The probe will be placed in the patient with an endoscopic procedure by a gastroenterologist (standard procedure for post-pyloric tubes placement).
Study NCT02142621 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: transpyloric feeding
Study NCT02142621 — intervention group
Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: gastric feeding
Study NCT00871000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Boostrix Polio™ 711866
Description: Single dose, intramuscular administration.
Study NCT00871000 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Priorix Tetra TM 208136
Description: Single dose, subcutaneously.
Study NCT00871000 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Priorix Tetra TM 208136
Description: Single dose, subcutaneously.
Study NCT00871000 — intervention group
Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Tetravac TM
Description: Single dose, intramuscular administration.
Study NCT02532946 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Bedsider.org counseling
Description: Contraceptive counseling was done while women kept the computer/tablet throughout their visit to facilitate discussion of website information with their providers.
Study NCT02168439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Dexmedetomidine
Study NCT02168439 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Midazolam
Study NCT02596984 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Caspofungin
Description: Either preemptive, empirical or curative prescription of Caspofungin by one of the ICUs' attending physician. Caspofungin will be administered according to the international recommendation
Study NCT02178436 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Selinexor
Description: Given IV
Study NCT02178436 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Pharmacological Study
Description: Correlative studies
Study NCT00574977 — intervention group
Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: Vaccinia virus (vvDD-CDSR)
Description: Eligible subjects will receive 1 infusion of vvDD-CDSR.~Cohort 1: 3 x 10e8 p.f.u; Cohort 2: 1 x 10e9 p.f.u.; Cohort 3: 3 x 10e9 p.f.u.
Study NCT02267577 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Sphygmo: Automatic Blood Pressure Monitor
Description: A team of engineers from Rice University has recently developed Sphygmo, an ambulatory, low-cost blood pressure monitor for use in the diagnosis and management of pre-eclampsia in low-resource hospitals.
Study NCT02267577 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: GE Dinamap ProCare Automatic Blood Pressure Monitor
Description: This commercially available gold standard blood pressure monitor will be used as a control to assess the accuracy of the Sphygmo device.
Study NCT04710589 — intervention group
Intervention type: RADIATION
Intervention: CTV
Description: According to the clinical conditions of the patients, they will be assigned to two groups based on the doctor's recommendations and their own wishes
Study NCT01803165 — intervention group
Intervention type: PROCEDURE
Intervention: Single shot femoral and sciatic nerve block
Description: Ultrasound will be performed with a linear 10- to 13-Megahertz probe while performing the nerve block. Standard American Society of Anesthesiology monitors will be applied and the patient sedated at the discretion of the anesthetic team. Complications such as vascular puncture, pain on injection, or systemic toxicity will be recorded. A perineural dosing regimen for the regional blocks will be as follows: (femoral block) 20cc of 0.5% ropivicaine and (sub-gluteal posterior sciatic block) 20cc of 0.2% ropivicaine. Epinephrine will be withheld from the local anesthetic in order to prevent the potential of further ischemic complications.
Study NCT02172222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: BI 10773
Study NCT02172222 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Linagliptin
Study NCT02718677 — intervention group
Intervention type: DRUG
Intervention: Refacto AF
Description: Observational - Non-Interventional Study
Study NCT02967120 — intervention group
Intervention type: OTHER
Intervention: no intervention
Study NCT01709799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Exercise
Description: Participants will do physical activity that raises heart rate to a target heart rate (THR)zone which is pre-calculated using the Karvonen Formula:~(THR={(max. heart rate- rest heart rate) x %intensity} + resting heart rate~Participants begin exercise regimen starting at 50% THR for intensity and gradually increase by 5% up to a maximum of 75% THR.~Activity duration begins at 10 mins./day and increases 5 mins. every week following to a maximum of 40 mins. Polar Heart Rate monitors are used to measure THR and save resulting data.
Study NCT01709799 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Exergames
Description: Participants experience Wii Video Games in a standardized format, beginning with 15 mins of seated play per day on week one, and then increasing 5 mins./week on each week following up to a maximum of 40mins. of play.~Participants are made aware of the Target Heart Rate Zone for the week, but are not required to reach that zone during play. The THR is calculated by the Karvonen Formula:~THR={(max. heart rate- rest heart rate) x %intensity} + resting heart rate~Polar Heart Rate monitors are used to measure THR and save resulting data.
Study NCT01709799 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Cognitive Training
Description: Posit Science INSIGHT program games are used for all cognitive training. Participants are exposed to (2) forty minute game sessions per day, for the cognitive training weeks #4,8,12,16.~INSIGHT Assessments are done at baseline, the start of each training week and at week 28.
Study NCT01709799 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Cognitive Training
Description: Posit Science INSIGHT program games are used for all cognitive training. Participants are exposed to (2) forty minute game sessions per day, for the cognitive training weeks #4,8,12,16.~INSIGHT Assessments are done at baseline, the start of each training week and at week 28.
Study NCT02740153 — intervention group
Intervention type: OTHER
Intervention: No Intervention Given
Study NCT01586663 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Serial night time position splint
Description: This group will use a serial night time position splint, adjusted monthly, during three months.
Study NCT01586663 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Drug treatment
Description: This patients will keep there drug treatment and will receive their splints on the end of the study.
Study NCT00318201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Erythromycin
Study NCT00318201 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Diltiazem
Study NCT02213757 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Premarin vaginal estrogen cream
Study NCT02213757 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo vaginal cream
Description: Inactive vaginal cream manufactured to mimic Premarin vaginal cream
Study NCT04050904 — intervention group
Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: ExpHeart
Description: ExpHeart is composed of an Information System (web application) and an algorithm, the Expert System, embedded on the Information System. The Information System is a cyber-securised web application and the Expert System uses a proprietary therapeutic algorithm to optimize pharmacological HF treatment. The Expert System is based on the analysis of a continuously updated clinical database integrating the patient's electronic medical record (managed by the Information System). The Expert System will generate prescription recommendations directed to the treating investigator through the Information System.
Study NCT04356001 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Socket preservation
Description: 'One-Piece' autologous tuberosity graft combining hard and soft tissue, harvested from the maxillary tuberosity, placed in extraction sockets.
Study NCT00003930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: cisplatin
Study NCT00003930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: gemcitabine hydrochloride
Study NCT00003930 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: paclitaxel
Study NCT00003930 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: conventional surgery
Study NCT06445335 — intervention group
Intervention type: DIAGNOSTIC_TEST
Group type: OTHER
Intervention: FibroScan
Description: Performance of a FibroScan measurement.
Study NCT00003930 — intervention group
Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: radiation therapy
Study NCT00756925 — intervention group
Intervention type: DRUG
Intervention: Acthrel
Description: 1 ug/kg, i.v., 1 minute
Study NCT03823378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Elsubrutinib
Description: Elsubrutinib capsule will be administered orally.
Study NCT03823378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Upadacitinib
Description: Upadacitinib tablet will be administered orally.
Study NCT03823378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for elsubrutinib
Description: Placebo capsule for elsubrutinib will be administered orally.
Study NCT03823378 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Placebo for upadacitinib
Description: Upadacitinib placebo tablet will be administered orally.
Study NCT01772511 — intervention group
Intervention type: BEHAVIORAL
Intervention: Questionnaire
Description: All patients entering on this trial will have been enrolled on an oncology clinical trial and are receiving active anti-cancer treatment on that study.
Study NCT01623986 — intervention group
Intervention type: DEVICE
Intervention: Mespere Venus 1000 System
Description: An adhesive patch (connected to the Mespere Venus 1000 System) is placed on the neck of the subject, to determine if the CVP values displayed by the device correlates with right atrial pressure values obtained by echocardiography(standard clinical practice)
Study NCT01623986 — intervention group
Intervention type: DEVICE
Intervention: Echocardiography machine
Description: Use of ultrasound to estimate right atrial pressure from analyzing inferior vena cava (IVC).
Study NCT01631019 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Mobile-phone-based Home Exercise Training Program
Description: Patients in the mobile phone group were asked to perform daily endurance exercise training under mobile phone guidance, and the adherence was reported back to the central server. The level of endurance walking was re-assessed and re-adjusted initially on regular clinical visits every four weeks during the first three months. During this period of time, the adherence to protocol was reinforced by telephone from health professionals whenever patients missed one day of their walking training detected by the central system. Patients were asked to continue their exercise program at home at a fixed walking speed, and return to the clinic at 1, 2, 3 and 6 months.
Study NCT01631019 — intervention group
Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Home Exercise Training Program
Description: all the subjects were assessed by an incremental shuttle walking test (ISWT) (24) for estimation of exercise endurance. Baseline spirometry and body mass index (BMI) were recorded. The adherence and compliance of the home-based exercise training program was assessed by monitoring the frequency of performance and the duration of the endurance walking program recorded on the central system every week. Patients were asked to continue their exercise program at home at a fixed walking speed, and return to the clinic at 1, 2, 3 and 6 months.
Study NCT01631019 — intervention group
Intervention type: BEHAVIORAL
Group type: ACTIVE_COMPARATOR
Intervention: Home Exercise Training Program
Description: all the subjects were assessed by an incremental shuttle walking test (ISWT) (24) for estimation of exercise endurance. Baseline spirometry and body mass index (BMI) were recorded. The adherence and compliance of the home-based exercise training program was assessed by monitoring the frequency of performance and the duration of the endurance walking program recorded on the central system every week. Patients were asked to continue their exercise program at home at a fixed walking speed, and return to the clinic at 1, 2, 3 and 6 months.
Study NCT00522964 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: behavioral intervention
Description: The intervention is based on Social Cognitive Theory and principles of Chinese culture and practices. The intervention program includes a one-hour small-group session for eight weeks for children and two 2-hour small-group sessions for parents.
Study NCT01055496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inotuzumab ozogamicin+rituximab +cyclophosphamide+vincristine+prednisone
Description: Day 1:~Rituximab at 375 mg/m2 Cyclophosphamide at 375 mg/m2 (cohort 1), 550mg/m2 (cohort 2), 750 mg/m2 (cohort 3, 4) Vincristine at 1.4 mg/m2 (max 2 mg)~Day 2 Inotuzumab ozogamicin at 0.8 mg/m2 (cohort 1, 2, 3), 1.3 mg/m2 (cohort 4)~Days 1-5:~Prednisone at 40 mg/m2~Each cycle is 3 weeks, with a maximum of 6 cycles total.
Study NCT01055496 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: inotuzumab ozogamicin+rituximab+gemcitabine+cisplatinum+dexamethasone
Description: Day 1:~Rituximab at 375 mg/m2 Gemcitabine at 500 mg/m2 (cohort 1, 2b, 3b), 1000mg/m2 (cohort 2a, 3a, 4, 5) Cisplatin at 37.5 mg/m2 (cohort 1, 2a), 50mg/m2 (cohort 2b, 3a), 75mg/m2 (cohort 3b, 4, 5)~Day 2:~Inotuzumab ozogamicin at 0.8 mg/m2 (cohort 1, 2a, 2b, 3a, 3b, 4), 1.3mg/m2 (cohort 5)~Days 1-4:~Dexamethasone at 40 mg~Each cycle is 3 weeks, with a maximum of 6 cycles total.
Study NCT04688879 — intervention group
Intervention type: PROCEDURE
Intervention: intra-arterial urokinase thrombolysis
Description: Under local anaesthesia, the right femoral artery was punctured in accordance with the Seldinger technique, and a 6-Fr sheath, 10 cm in length, was implanted. Selective catheterization of the SMA was performed with 4-Fr catheter. The SMA angiography was performed to identify the filling defect. Thrombolysis was performed using a 5-Fr multiple-sideport infusion catheter (100cm with sideport of 7cm, 14 ports or 100cm with sideport of 15cm, 30 ports, Cook, Bloomington, IN, U.S.A). The tip of the microcatheter was embedded in the thromboembolism, which was fragmented at the time of thrombolysis. Thrombolysis was performed locally in the SMA with a bolus of urokinase
Study NCT02240147 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: home-based exercise training
Description: During a 30 minute face-to-face motivational interview with an exercise specialist, the patient will be advised and coached about his exercise prescription, on how to implement it in his own daily life and on how to prevent relapse. Furthermore, the patients will receive instructions on how to monitor their exercise intensity and on recognizing adverse signals. During the following 12 weeks, patients will be asked to exercise 4.5 hours per week within the prescribed exercise intensity range according to the guidelines.
Study NCT00597337 — intervention group
Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: FearNot
Description: Behavioral: Three sessions of FearNot!v.2.0 software interaction over a three-week period (each session lasting approximately 30 minutes)
Study NCT03446261 — intervention group
Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rosuvamibe® Tab
Description: Rosuvastatin 5mg/ezetimibe 10mg qd for 8 weeks
Study NCT03446261 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Monorova® Tab
Description: Rosuvastatin 10mg qd for 8 weeks
Study NCT01007682 — intervention group
Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Show distressing movie and tell half of the two study groups to suppress memories of the movie
Description: A distressing movie is presented to two groups (one group with high and one group with low working memory capacity). For each of the two groups, half of the participants are instructed to suppress thoughts of the movies after viewing it, while the remaining participants are instructed to allow the occurrence of memories of the movie.
Study NCT04195737 — intervention group
Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: Ossix volumax collagen matrix
Description: Under LA horizontal incision is made.Split-full-split thickness flap is elevated.The remaining soft tissue of the anatomic interdental papillae deepithelialized.Coronal advancement of the flap obtained and closed using sling suture.
Study NCT04195737 — intervention group
Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: Connective Tissue Graft
Description: Under LA parallel incisions is made 1-2 mm first molar to canine.Graft incision 1 mm coronal to the horizontal flap incision.Through this incision designed graft thickness is obtained.The graft obtained between the two horizontal incisions has a 1 mm coronal strip that require depithelisation with a knife and closed using interrupted suture.
Study NCT01754909 — intervention group
Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Enalapril
Description: Enalapril once a day, orally, as 2.5 , 5, or 10 mg tablets to be given in escalating doses, to subjects undergoing radiotherapy for lung cancer
Study NCT01754909 — intervention group
Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: placebo
Description: Placebo, once a day, orally, as 2.5 , 5, or 10 mg tablets to be given in escalating doses, to subjects undergoing radiotherapy for lung cancer